Yunkang Group Limited (HKG:2325)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.920
+0.010 (1.10%)
Mar 10, 2026, 11:51 AM HKT
-80.59%
Market Cap 532.66M
Revenue (ttm) 706.95M
Net Income (ttm) -789.94M
Shares Out 585.34M
EPS (ttm) -1.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,536,000
Average Volume 2,451,000
Open 0.900
Previous Close 0.910
Day's Range 0.900 - 1.090
52-Week Range 0.650 - 5.000
Beta -0.77
RSI 60.57
Earnings Date Mar 27, 2026

About Yunkang Group

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic test... [Read more]

Sector Healthcare
Founded 2008
Employees 1,146
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2325
Full Company Profile

Financial Performance

In 2024, Yunkang Group's revenue was 711.88 million, a decrease of -20.15% compared to the previous year's 891.50 million. Losses were -791.68 million, 674.2% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.